Triple fixed drug combinations in type 2 diabetes
- PMID: 25932383
- PMCID: PMC4366766
- DOI: 10.4103/2230-8210.152739
Triple fixed drug combinations in type 2 diabetes
Conflict of interest statement
References
-
- Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38:140–9. - PubMed
-
- Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med. 1998;15:297–303. - PubMed
-
- Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: A retrospective cohort study. Diabet Med. 2002;19:279–84. - PubMed
-
- Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care. 2008;14:71–5. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources